(Q35557414)

English

Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.

scientific article published on May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Sally Dowen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Gillian Turnbull

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Frans van den Berg

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Chun-Mei Zhao

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Duan Chen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

James Black

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

0 references

publication date

1 May 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

79

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

744-755

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

In vivo analysis of mouse gastrin gene regulation in enhanced GFP-BAC transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Control of gastric acid secretion in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Attack and defence in the gastric epithelium - a delicate balance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Cholecystokinin antagonists: pharmacological and therapeutic potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Validation of a liquid chromatographic-tandem mass spectrometric method for the measurement of (R)-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea (YF476) in human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

The gastrins: their production and biological activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Review article: the pharmacokinetics of rabeprazole in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Helicobacter pylori infection and chronic gastric acid hyposecretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Marked increase in gastric acid secretory capacity after omeprazole treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4415711

27 July 2018

Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Review article: Pathogenesis and management of gastric carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas

1 reference

https://api.crossref.org/works/10.1111%2FBCP.12534

21 January 2018

Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25335860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach

1 reference

https://pubmed.ncbi.nlm.nih.gov/25335860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25335860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas")

1 reference

https://pubmed.ncbi.nlm.nih.gov/25335860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25335860

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BCP.12534

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25335860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35557414&oldid=1525254972"